Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05128955 · ClinicalTrials.gov registry record · NA
Embolization of the Splenic Artery After Trauma
A NA study of High-grade Splenic Injuries, sponsored by Andrew J. Gunn.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 5
- Study locations
NCT05128955: Recruiting NA study of High-grade Splenic Injuries, sponsored by Andrew J. Gunn.
NCT05128955 is a NA study of High-grade Splenic Injuries that is actively recruiting participants, run by Andrew J. Gunn. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05128955, a NA study of High-grade Splenic Injuries, is actively recruiting participants, sponsored by Andrew J. Gunn.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 5
- Study locations
Study Summary
Our aim is to conduct a multi-center, Bayesian, randomized clinical trial to evaluate the primary technical success of coils and vascular plugs for proximal splenic artery embolization in the setting of high-grade splenic trauma. The investigator has previously demonstrated the feasibility of such a study in a single center pilot trial.
Primary Outcome
The ability to deploy the assigned embolic device in the mid-splenic artery with resultant occlusion of the artery within 15 minutes of deployment.
Conditions Studied
Interventions
- DEVICE Splenic artery embolization with vascular embolic coils or plugs
Study Locations (5)
Alabama
- University of Alabama at Birmingham - Birmingham
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Ohio
- Ohio State University Medical Center - Columbus
South Carolina
- Prisma Health - Greenville
Texas
- The University of Texas Health Science Center at Houston McGovern Medical School - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-05-10 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05128955 shows while recruiting
NCT05128955 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with High-grade Splenic Injuries appearing as the primary indexed condition, and to 1 intervention - of which Splenic artery embolization with vascular embolic coils or plugs is the first listed.
NCT05128955 lists 5 locations in 5 states (Alabama, North Carolina, Ohio).
Frequently Asked Questions
What is clinical trial NCT05128955 about?
NCT05128955 is a clinical study titled "Embolization of the Splenic Artery After Trauma". Our aim is to conduct a multi-center, Bayesian, randomized clinical trial to evaluate the primary technical success of coils and vascular plugs for proximal splenic artery embolization in the setting of high-grade splenic trauma. The investigator has previously demonstrated the feasibility of such a...
What is the current status of trial NCT05128955?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2022-05-10. Estimated completion is 2026-12.
What conditions does trial NCT05128955 study?
This clinical trial studies the following conditions: High-grade Splenic Injuries.
What interventions are being tested in trial NCT05128955?
The interventions under investigation include: Splenic artery embolization with vascular embolic coils or plugs (DEVICE).
Who is sponsoring clinical trial NCT05128955?
This trial is sponsored by Andrew J. Gunn, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05128955 being conducted?
This trial has 5 study locations across Alabama, North Carolina, Ohio, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05128955's enrollment target sits among peer trials
250 410th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI